Search research articles
Contact Us
Filters
Showing results (51-60 of 58) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 58 results.
Advances in Radiation Oncology
|
March 10, 2023
Radiation Therapy in the German Hodgkin Study Group HD 16 and HD 17 Trials: Quality Assurance and Dosimetric Analysis for Hodgkin Lymphoma in the Modern Era
Michael Oertel, Dominik Hering, Nina Nacke, et al.
Scientific Reports
|
August 2, 2018
Magnetoliposomes as Contrast Agents for Longitudinal in vivo Assessment of Transplanted Pancreatic Islets in a Diabetic Rat Model
Rita Sofia Garcia Ribeiro, Conny Gysemans, João Paulo Monteiro Carvalho Mori da Cunha, et al.
Acta Neurochirurgica
|
June 1, 2019
Clinical, radiological, and histopathological predictors for long-term prognosis after surgery for atypical meningiomas
Eileen Maria Susanne Streckert, Katharina Hess, Peter B Sporns, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 24, 2026
Three-dimensional radiotherapy target volume definitions for osteoarthritis - Consensus statement of the International Benign Target Volume Group (IBTVG)
David Rene Steike, Michael Heinrich Seegenschmiedt, Richard Shaffer, et al.
British Journal of Haematology
|
August 28, 2015
Impact of centralized diagnostic review on quality of initial staging in Hodgkin lymphoma: experience of the German Hodgkin Study Group
Paul J Bröckelmann, Helen Goergen, Michael Fuchs, et al.
Frontiers in Immunology
|
October 27, 2025
From essential basic understanding to clinical application - biological, physical and pathophysiological principles of (low-dose) radiotherapy in benign diseases
Lisa Deloch, David Rene Steike, Felix Pascher, et al.
Lancet (London, England)
|
December 26, 2014
Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial
Karolin Behringer, Helen Goergen, Felicitas Hitz, et al.
JAMA Oncology
|
July 9, 2026
Consolidative Thoracic Radiotherapy With Atezolizumab Maintenance in Extensive-Stage Small Cell Lung Cancer: The Phase 2 TREASURE Randomized Clinical Trial (AIO-TRK-0320)
Farastuk Bozorgmehr, Inn Chung, Rouven Behnisch, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 58) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 58 results.
Advances in Radiation Oncology
|
March 10, 2023
Radiation Therapy in the German Hodgkin Study Group HD 16 and HD 17 Trials: Quality Assurance and Dosimetric Analysis for Hodgkin Lymphoma in the Modern Era
Michael Oertel, Dominik Hering, Nina Nacke, et al.
Scientific Reports
|
August 2, 2018
Magnetoliposomes as Contrast Agents for Longitudinal in vivo Assessment of Transplanted Pancreatic Islets in a Diabetic Rat Model
Rita Sofia Garcia Ribeiro, Conny Gysemans, João Paulo Monteiro Carvalho Mori da Cunha, et al.
Acta Neurochirurgica
|
June 1, 2019
Clinical, radiological, and histopathological predictors for long-term prognosis after surgery for atypical meningiomas
Eileen Maria Susanne Streckert, Katharina Hess, Peter B Sporns, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 24, 2026
Three-dimensional radiotherapy target volume definitions for osteoarthritis - Consensus statement of the International Benign Target Volume Group (IBTVG)
David Rene Steike, Michael Heinrich Seegenschmiedt, Richard Shaffer, et al.
British Journal of Haematology
|
August 28, 2015
Impact of centralized diagnostic review on quality of initial staging in Hodgkin lymphoma: experience of the German Hodgkin Study Group
Paul J Bröckelmann, Helen Goergen, Michael Fuchs, et al.
Frontiers in Immunology
|
October 27, 2025
From essential basic understanding to clinical application - biological, physical and pathophysiological principles of (low-dose) radiotherapy in benign diseases
Lisa Deloch, David Rene Steike, Felix Pascher, et al.
Lancet (London, England)
|
December 26, 2014
Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial
Karolin Behringer, Helen Goergen, Felicitas Hitz, et al.
JAMA Oncology
|
July 9, 2026
Consolidative Thoracic Radiotherapy With Atezolizumab Maintenance in Extensive-Stage Small Cell Lung Cancer: The Phase 2 TREASURE Randomized Clinical Trial (AIO-TRK-0320)
Farastuk Bozorgmehr, Inn Chung, Rouven Behnisch, et al.
Page
of 6